https://www.selleckchem.com/pr....oducts/BIRB-796-(Dor
5% versus 35.9%, 6.6 (95% confidence interval 5.9-12.5) versus 7.6 months (3.9-12.3) and 19.6 (13.4-22.9) versus 17.9 months (13.4-23.9), respectively. Grade 3-4 neutropenia and diarrhoea during induction mFOLFIRINOX and GOFL were 37.0% versus 21.4% and 14.8% versus 3.6%, respectively. Induction GOFL and mFOLFIRINOX followed by CCRT provided similar clinical outcomes in LAPC patients. CLINICALTRIAL. NCT01867892. NCT01867892. B lymphocytes have multifaceted functions in the tumour microenvironment, and their prognostic rol
Like
Comment
Share
